Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-28

FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved an original-application generic formulation of dihydroergotamine mesylate from Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

ORIG AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)